Shanda Group

Shanda Group, founded in 1999 by Tianqiao Chen and Chrissy Luo, is a private investment firm that focuses on venture capital, private equity, public markets, and real estate. The firm prioritizes investments in the financial services, technology, and healthcare sectors, seeking innovative companies and strong management teams with transformative potential. Headquartered in Redwood City, California, Shanda Group operates additional offices in Shanghai, Hong Kong, New York, and Singapore, allowing it to maintain a global investment perspective. Through its diverse investment strategy, Shanda Group aims to support the growth of companies that can make significant impacts in their respective industries.

Tianqiao Chen

Co-Founder, CEO and Chairman

Chrissy Luo

Co-Founder, Vice Chairwoman and President

35 past transactions

Xunlu AI

Series B in 2024
Xunlu AI is a pioneering startup specializing in AI-driven customer service and marketing solutions. It offers tailored AI technologies, including intelligent customer service and sales robots, to businesses across diverse industries. The company's flagship product is a fully automatic, one-stop AI middle platform for marketing, powered by AIGC (Artificial Intelligence Generated Content) and RPA (Robotic Process Automation). This platform provides efficient, multi-language AI marketing tools to a wide range of Chinese companies, aiming to reduce costs and enhance productivity.

Rubedo Life Sciences

Series A in 2024
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing innovative therapies that target senescent cells implicated in age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of therapeutic candidates. These candidates are designed to selectively address senescent cells, as well as pro-inflammatory and pro-fibrotic cell populations that contribute to various chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises industry experts with significant experience in drug development and commercialization across both large pharmaceutical companies and biotech firms.

Mojo Vision

Series A in 2023
Mojo Vision Inc. is a technology company based in Saratoga, California, founded in 2015. The company specializes in the development of augmented reality solutions, focusing on high-performance micro-LED display technology. Mojo Vision has created the world's smallest and densest dynamic display for smart contact lenses, which are designed to provide users with timely information seamlessly and hands-free, without the distractions associated with traditional mobile devices. The company is also engaged in a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products, further enhancing its innovative offerings. By combining advanced display and semiconductor expertise with proprietary quantum-dot technology, Mojo Vision aims to revolutionize the display industry, addressing diverse applications across consumer, enterprise, and government sectors.

DigiFT

Seed Round in 2023
DigiFT Tech is a company focused on providing regulated decentralized finance solutions on the Ethereum blockchain. It operates a regulatory-compliant digital asset exchange that allows asset owners to issue blockchain-based security tokens. This platform facilitates trading with continuous liquidity through an Automatic Market Maker mechanism. DigiFT Tech's decentralized platform enables users to trade using fiat currency, as well as transfer funds to various wallets, ensuring compliance with regulatory standards while engaging in decentralized finance products. The company's innovations aim to enhance the accessibility and efficiency of blockchain trading.

Jimeng Intelligent

Series A in 2023
Jimeng Intelligent is a technology-driven company specializing in the industrial Internet sector, focusing on the manufacturing industry. It has developed a comprehensive digital factory platform that incorporates extensive data storage and advanced analytical frameworks. This platform enables real-time monitoring of various factors in the manufacturing process, including equipment status, environmental conditions, and staffing capacity. By utilizing machine learning and big data visualization, Jimeng Intelligent provides insights through data mining and analysis, allowing clients to achieve adaptive control and enhance operational efficiency. The company's offerings aim to meet the digital and intelligent needs of modern manufacturing facilities.

Synchron

Series C in 2022
Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

WhizAI

Series A in 2022
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.

Socialtrait

Seed Round in 2022
Socialtrait is a developer of AI-powered solutions focused on predicting, measuring, and enhancing the performance of brand concepts. The company's platform provides a suite of tools that include reputation risk management, audience insights, competitive analysis, and rapid A/B testing. These tools empower brands to make informed decisions regarding their content strategies, ultimately driving increased engagement and success. By leveraging advanced technology, Socialtrait aims to support brands in navigating the complexities of modern marketing and optimizing their overall performance in the marketplace.

turn.bio

Venture Round in 2022
Turn.bio is a biotechnology company focused on developing innovative therapies aimed at reversing aging and age-related diseases. Leveraging a patented mRNA platform technology known as ERA, along with a specialized delivery system called eTurna, the company targets the epigenome to restore optimal gene expression. By designing tailored therapies, Turn.bio addresses a range of conditions, including immune-related diseases such as cancer, dermatological issues, and ailments in ophthalmology, osteoarthritis, and the muscular system. The company's approach involves inducing the body to heal itself by instructing specific cells to combat disease and repair damaged tissue, thereby reprogramming cellular functions to enhance health and longevity.

WhizAI

Series A in 2021
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.

Pear Therapeutics

Post in 2021
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Ombre

Seed Round in 2021
Ombre is a company that specializes in microbiome testing, providing a testing kit that combines personalized probiotics with microbiome analysis. The company's offerings include subscription-based customized testing, which delivers science-backed probiotics tailored to individual needs. This approach aims to provide actionable insights for the prevention of chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By focusing on the root causes of gut health issues, Ombre enables customers to better understand and improve their microbiome, promoting overall wellness.

Synchron

Series B in 2021
Synchron is a medical technology company focused on developing innovative brain-computer interface solutions. It manufactures an implantable device known as the stentrode, which is delivered to the brain via a catheter. This minimally invasive device is embedded with electrode arrays that can interpret neuronal signals and modulate neural activity in targeted areas. By enabling patients with motor impairments to control digital devices, prosthetics, and other assistive technologies through thought, Synchron aims to enhance the quality of life for individuals with disabilities.

turn.bio

Funding Round in 2021
Turn.bio is a biotechnology company focused on developing innovative therapies aimed at reversing aging and age-related diseases. Leveraging a patented mRNA platform technology known as ERA, along with a specialized delivery system called eTurna, the company targets the epigenome to restore optimal gene expression. By designing tailored therapies, Turn.bio addresses a range of conditions, including immune-related diseases such as cancer, dermatological issues, and ailments in ophthalmology, osteoarthritis, and the muscular system. The company's approach involves inducing the body to heal itself by instructing specific cells to combat disease and repair damaged tissue, thereby reprogramming cellular functions to enhance health and longevity.

Pear Therapeutics

Series D in 2020
Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Rubedo Life Sciences

Seed Round in 2020
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing innovative therapies that target senescent cells implicated in age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of therapeutic candidates. These candidates are designed to selectively address senescent cells, as well as pro-inflammatory and pro-fibrotic cell populations that contribute to various chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises industry experts with significant experience in drug development and commercialization across both large pharmaceutical companies and biotech firms.

Phaseshift Technologies

Pre Seed Round in 2020
PhaseShift Technologies is addressing the critical need for new materials that can overcome limitations in performance, efficiency, cost, availability, and sustainability. Traditional material development relies heavily on trial-and-error, requiring costly and time-consuming physical experiments. This approach can extend projects over 10-20 years and cost millions of dollars, with no guarantee of success. PhaseShift's Rapid Alloy Design (RAD)™ technology revolutionizes this process by using AI to create optimized alloys tailored to specific use cases. Paired with Multi-Scale Simulations to accurately predict material performance, RAD™ minimizes the time and effort spent on unsuccessful trials. This leads to faster, more efficient development cycles and a significant reduction in resources required to meet design goals. Through the RAD™ platform, PhaseShift designs a portfolio of innovative alloys, which are commercialized via strategic partnerships with manufacturers.

Vectorly

Pre Seed Round in 2020
Vectorly Inc. is a video learning platform that serves both companies and students, utilizing advanced technology to enhance video experiences. Founded in 2015 and based in New York, with an additional office in Bengaluru, India, the company was formerly known as Dot Learn Inc. and rebranded to Vectorly in 2018. It specializes in AI-based video enhancement, employing patented technology to upscale and improve video quality in real-time on users' devices, regardless of network conditions. This innovation allows video streaming platforms to significantly reduce cloud storage and delivery costs while providing a seamless viewing experience. In December 2021, Vectorly was acquired by Hopin, further expanding its reach in the video technology space.

Iota Biosciences

Series A in 2018
Iota Biosciences, Inc. is a medical device company based in Berkeley, California, founded in 2017. The company specializes in developing innovative bioelectronic devices that utilize wireless sensors to monitor, measure, and stimulate internal nerves, muscles, and organs for electroceutical applications aimed at treating immune and neural disorders. Iota's technology is built on pioneering ultrasound advancements from the University of California, Berkeley, and includes implantable, mote-sized ultrasonic sensors that facilitate completely wireless neural recordings. This approach eliminates the need for tethered connections, allowing for real-time monitoring and improved treatment of diseases. As a subsidiary of Astellas Pharma Inc., Iota Biosciences is committed to delivering safe and effective diagnostic and therapeutic solutions that transform disease management and significantly enhance patient care.

Mojo Vision

Series A in 2018
Mojo Vision Inc. is a technology company based in Saratoga, California, founded in 2015. The company specializes in the development of augmented reality solutions, focusing on high-performance micro-LED display technology. Mojo Vision has created the world's smallest and densest dynamic display for smart contact lenses, which are designed to provide users with timely information seamlessly and hands-free, without the distractions associated with traditional mobile devices. The company is also engaged in a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products, further enhancing its innovative offerings. By combining advanced display and semiconductor expertise with proprietary quantum-dot technology, Mojo Vision aims to revolutionize the display industry, addressing diverse applications across consumer, enterprise, and government sectors.

Krisp

Seed Round in 2018
Krisp is a technology company that offers an AI-powered application designed to enhance remote communication by eliminating background noise and ensuring clear audio quality during calls and meetings. The app is compatible with all conferencing and recording platforms, allowing users to take calls from any location without concerns about privacy or environmental noise. Krisp's advanced technology not only cancels unwanted sounds but also recovers lost audio packets during network transfers, transforming low-bitrate audio into high-definition quality. This makes it particularly beneficial for contact centers, telecommunications, and critical communications, enabling existing audio devices to deliver enhanced communication experiences.

Ombre

Seed Round in 2018
Ombre is a company that specializes in microbiome testing, providing a testing kit that combines personalized probiotics with microbiome analysis. The company's offerings include subscription-based customized testing, which delivers science-backed probiotics tailored to individual needs. This approach aims to provide actionable insights for the prevention of chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By focusing on the root causes of gut health issues, Ombre enables customers to better understand and improve their microbiome, promoting overall wellness.

Teambrella

Seed Round in 2018
Teambrella Inc. operates a bitcoin-based peer-to-peer insurance platform that enables users to mutually cover each other’s claims. Founded in 2015 and headquartered in Saint Petersburg, Russia, the company provides innovative insurance solutions, including deductible supplement coverage for collision insurance and pet insurance that addresses veterinary expenses. Teambrella aims to redefine the insurance experience by fostering a community-driven approach, where users align their interests and collaboratively manage risks, ensuring a fair and transparent process. Through its technology, Teambrella seeks to replace traditional insurance models by leveraging social connections and peer support.

Nextbiotics

Pre Seed Round in 2018
Nextbiotics is a biotechnology platform based in Mountain View, California, founded in 2017. The company specializes in engineering viruses, specifically bacteriophages, to combat antibiotic-resistant bacteria. By integrating bacteriophage therapy with CRISPR technology, Nextbiotics develops innovative treatments aimed at reversing antibiotic resistance and addressing global health challenges related to drug-resistant infections. The platform's capabilities allow for precise modulation of the microbiome, providing medical professionals with effective tools to treat and prevent infections that are resistant to conventional antibiotics.

Shihou TV

Series A in 2018
Shanghai Shihou Network Technology Co., Ltd. is a private company based in Shanghai, China, that operates a mobile gaming and live broadcasting platform. The platform caters to the entertainment sector by providing a diverse selection of online and real-time games, aimed at enhancing user engagement and entertainment experiences. Through its services, Shihou TV connects gamers and viewers, facilitating a dynamic environment for gaming and entertainment.

Teambrella

Seed Round in 2017
Teambrella Inc. operates a bitcoin-based peer-to-peer insurance platform that enables users to mutually cover each other’s claims. Founded in 2015 and headquartered in Saint Petersburg, Russia, the company provides innovative insurance solutions, including deductible supplement coverage for collision insurance and pet insurance that addresses veterinary expenses. Teambrella aims to redefine the insurance experience by fostering a community-driven approach, where users align their interests and collaboratively manage risks, ensuring a fair and transparent process. Through its technology, Teambrella seeks to replace traditional insurance models by leveraging social connections and peer support.

HOTEL NIDA

Series A in 2017
HOTEL NIDA is a branded budget hotel internet marketplace. The company's website provides information about trip destinations, hotel pricing, and lodging availability. It allows consumers to look for, compare, and book services after entering pertinent information.

Survios

Series B in 2016
Survios, Inc. is a virtual reality company based in Los Angeles, California, founded in 2012. The company specializes in creating innovative interactive content and immersive gaming experiences powered by advanced virtual reality technology. Originating from Project Holodeck, an initiative at the University of Southern California’s Games program, Survios was established by Nathan Burba, James Iliff, and Alexander Silkin. The company's focus is on developing engaging games that offer users a rich combination of visuals, sound, tactile feedback, and dynamic spectating, aiming to elevate the overall gaming experience. Survios is dedicated to pushing the boundaries of immersive technology in the gaming industry.

Lumus

Series C in 2016
Lumus, Ltd. is an Israeli company specializing in the development and manufacturing of wearable augmented reality (AR) displays for smart eyewear manufacturers. Founded in 2000 and based in Ness Ziona, Lumus utilizes its patented Light-guide Optical Element (LOE) technology to create transparent displays that seamlessly blend digital information with the physical world. This innovative technology allows for lightweight designs, a wide field of view, and true see-through performance, making it an attractive option for leading producers of smart glasses and augmented reality eyewear. In addition to its display products, Lumus also provides development kits for original equipment manufacturer (OEM) customers, supporting the integration of their advanced display technology into various smart wearable devices.

SpaceVR

Seed Round in 2016
SpaceVR is a virtual reality company founded in January 2015 and based in San Francisco, California. It operates a platform that enables users to immerse themselves in space experiences through mobile, desktop, and virtual reality devices. The company utilizes technology that streams footage from low Earth orbit, allowing users to engage with space travel in a deeply immersive manner. SpaceVR's innovative offerings include applications such as Orbit Therapy, which provides therapeutic benefits by simulating the experience of orbiting Earth, and a language learning program designed to accelerate language acquisition. By combining entertainment with educational and therapeutic elements, SpaceVR aims to enhance the way individuals interact with and learn about the universe.

Atheer

Series B in 2015
Atheer is a pioneer in augmented reality technology, focusing on enhancing productivity and safety for deskless professionals across various industries. The company's AiR™ platform includes AiR Glasses, which are designed to provide an interactive 3D experience, and the Android-based AiR OS. The AiR Enterprise Suite allows users to collaborate with remote experts through video calls and real-time image annotations, all while maintaining focus on their tasks. By utilizing familiar gestures and voice commands, users can access and engage with essential work information seamlessly. Atheer's open AiR SDK enables developers and businesses to create tailored enterprise applications and workflows, making the platform suitable for high-value tasks in sectors such as industrial, energy, healthcare, insurance, construction, and logistics.

UploadVR

Seed Round in 2015
Upload is dedicated to accelerating the success of the VR + AR (XR) industry through inspiring educational experiences.

ElMindA

Series C in 2015
ElMindA is an Israeli company based in Herzliya, with an additional office in Glenview, Illinois, founded in 2006. It specializes in developing a tool for diagnosing, monitoring, and treating brain-related disorders using its proprietary Brain Network Activation (BNA) technology. This technology integrates electroencephalography, event-related potential testing, machine learning, advanced algorithms, and large-population databases to visualize and evaluate the complex neuro-physiological interconnections of the human brain in action. By capturing detailed electrophysiological patterns related to specific functions evoked by repeatable tasks, BNA creates high-resolution, three-dimensional representations of functional neural pathways. These representations help assess brain function and health, aiding in the management of conditions such as mild traumatic brain injury, major depressive disorder, Parkinson’s disease, multiple sclerosis, ADHD, and mild cognitive impairment.

Sólfar

Seed Round in 2015
Sólfar Studios is a virtual reality gaming studio founded by three industry veterans with over 20 years of experience in online worlds, games, and virtual reality. The company specializes in creating and publishing games across major VR platforms such as PlayStation, Steam VR, and Oculus Rift. With a focus on delivering transformative experiences, Sólfar Studios aims to forge new pathways in virtual reality, allowing users to engage with immersive environments that evoke visceral emotions. The studio is known for its selective approach to talent and collaboration, maintaining a nimble profile while adhering to a strong commitment to the quality and impact of its productions.

Yunniao Delivery

Series A in 2015
Yunniao Delivery, established in November 2014, specializes in regional and city distribution services, focusing on B2B and O2O supply chain solutions. The company connects Chinese enterprises requiring same-city courier services with individuals who offer transportation using vans. This platform is designed to provide personalized services to a diverse clientele, including chain stores, distributors, brands, and manufacturers. Yunniao Delivery enhances customer experience through on-site monitoring, management, and the provision of insured goods along with cash-on-delivery options, ensuring a reliable and efficient distribution network.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.